View - ResearchSpace@Auckland - The University of Auckland

Prieto, L., L. Bruno, et al. (2003). "Ainray responsiveness to adenosine 5'-monophosphate
and exhaled nitric oxide measurements: predictive value as markers for reducing the
dose of inhaled corticosteroids in asthmatic subjects." Chest 124@): 1325-33.
Prieto, L., V. Gutierrez, et al. (2002). "Effect of salmeterol on seasonal changes in airway
responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects." Chest
122(3):798-805.
Prieto, L., V. Gutierrez, et al. (2002). "Exhaled nitric oxide and bronchial responsiveness to
adenosine 5'-monophosphate in subjects with allergic rhinitis." Chest 12l(6):1853-9.
Prieto, L., V. Gutierrez, et al. (2002). "Concentrations of exhaled nitric oxide in asthmatics
andsubjectswithallergicrhinitissensitizedtothesamepollenallergen.''@
Experimental Allersv 321D: l7 28-33.
Prieto, L., S. Uixera, et al. (2A0D. "Modifications of airway responsiveness to adenosine 5'monophosphate
and exhaled nitric oxide concentrations after the pollen season in
subj ects with pollen-induced rhiniti s. " Chest 122(3): 9 40 -7 .
Pryor, W. A. (1992). "How far does ozone penetrate into the pulmonary air/tissue boundary
before it reacts?" Free Radical Biolog), & Medicine 12(l): 83-8.
Pryor, W. A., G. L. Squadrito, et al. (1995). "A new mechanism for the toxicity of ozone."
Toxicology ktters 82-83: 287-93.
Quanjer, P. H. (1992). "A l0 year follow up of 180 adults with bronchial asthma: factors
important for the decline in lung function." Thorax 47(Q: a8a.
Quanjer, P. H., P. D. Sly, et d. (1995). "Respiratory function measurements in infants:
symbols, abbreviations and units." European Respiratory Journal E(6): 1039-56.
Quinlan, G. J., N. J. Lamb, et al. (1996). "Plasma fatty acid changes and increased lipid
peroxidation in patients with adult respiratory distress syndrome." Critical Care
Medicine ?A(2):241-6.
Qureshi, M. A., N. J. Shah, et al. (2W3). "Exposure of intensive care unit nurses to nitric
oxide and nitrogen dioxide during therapeutic use of inhaled nitric oxide in adults with
acute respiratory distress syndrome." American Journal of Critical Care l2(2): I47-53.
Quyyumi, A. A., D. Mulcahy, et al. (1997). "Coronary vascular nitric oxide activity in
hypertension and hypercholesterolemia. Comparison of acetylcholine and substance
P."Circulalion95(1): 104-10.
Raaschou-Nielsen, O., M. L. Nielsen, et al. (1995). "Traffic-related air pollution: exposure
andhealtheffectsinCopenhagenstreetcleanersandcemeteryworkers.''@f
Environmental Health 50(3): 2O7 -13.
Rachmilewitz,D., J. S. Stamler, et al. (1995). "Enhanced colonic nitric oxide generation and
nitric oxide synthase activity in ulcerative colitis and Crohn's disease." Gut 36(5): 718-
23.
Radi, R. (1996). "Reactions of nitric oxide with metalloproteins." Chemical Research in
Toxicology 9(5): 828-35.
Radomski, M. W., R. M. Palmer, et al. (1987). "The anti-aggregating properties of vascular
endothelium: interactions between prostacyclin and nitric oxide." MLlournalpf
Pharmacology 92(3): 639 46.
Radomski, M. W., R. M. Palmer, et al. (1987). "The role of nitric oxide and cGMP in platelet
adhesion to vascular endothelium." Biochemical & Biophysical Research
Communications 148(3): L482-9.
Rai, R. M., F. Y. Lee, et al. (1998). "Impaired liver regeneration in inducible nitric oxide
synthasedeficient mice." Proceedings of the National Academy of Sciences of the
United States of America 95(23): 13829-34.
Ramirez, J. and A. R. Dowell (1971). "Silo-filler's disease: nitrogen dioxide-induced lung
injury. Long-term follow-up and review of the literature." Annals of Internal Medicine
74@): s69-76.
332